1. Home
  2. FFA vs XOMA Comparison

FFA vs XOMA Comparison

Compare FFA & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFA
  • XOMA
  • Stock Information
  • Founded
  • FFA 2004
  • XOMA 1981
  • Country
  • FFA United States
  • XOMA United States
  • Employees
  • FFA N/A
  • XOMA N/A
  • Industry
  • FFA Investment Managers
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFA Finance
  • XOMA Health Care
  • Exchange
  • FFA Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • FFA 416.6M
  • XOMA 355.6M
  • IPO Year
  • FFA N/A
  • XOMA N/A
  • Fundamental
  • Price
  • FFA $20.60
  • XOMA $26.14
  • Analyst Decision
  • FFA
  • XOMA Strong Buy
  • Analyst Count
  • FFA 0
  • XOMA 2
  • Target Price
  • FFA N/A
  • XOMA $81.50
  • AVG Volume (30 Days)
  • FFA 26.1K
  • XOMA 30.4K
  • Earning Date
  • FFA 01-01-0001
  • XOMA 11-07-2024
  • Dividend Yield
  • FFA 6.72%
  • XOMA N/A
  • EPS Growth
  • FFA N/A
  • XOMA N/A
  • EPS
  • FFA N/A
  • XOMA N/A
  • Revenue
  • FFA N/A
  • XOMA $21,606,000.00
  • Revenue This Year
  • FFA N/A
  • XOMA $509.54
  • Revenue Next Year
  • FFA N/A
  • XOMA $26.20
  • P/E Ratio
  • FFA N/A
  • XOMA N/A
  • Revenue Growth
  • FFA N/A
  • XOMA 389.82
  • 52 Week Low
  • FFA $15.84
  • XOMA $16.00
  • 52 Week High
  • FFA $19.30
  • XOMA $35.00
  • Technical
  • Relative Strength Index (RSI)
  • FFA 50.14
  • XOMA 34.87
  • Support Level
  • FFA $20.92
  • XOMA $27.01
  • Resistance Level
  • FFA $21.14
  • XOMA $30.86
  • Average True Range (ATR)
  • FFA 0.19
  • XOMA 1.25
  • MACD
  • FFA -0.04
  • XOMA -0.54
  • Stochastic Oscillator
  • FFA 0.00
  • XOMA 1.63

About FFA First Trust Enhanced Equity Income Fund

First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide a high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Share on Social Networks: